597 related articles for article (PubMed ID: 26656713)
1. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection.
Kang MC; Park HW; Choi DH; Choi YW; Park Y; Sung YC; Lee SW
Immune Netw; 2017 Oct; 17(5):343-351. PubMed ID: 29093655
[TBL] [Abstract][Full Text] [Related]
3. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
[TBL] [Abstract][Full Text] [Related]
4. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
Stevenson PG; Hawke S; Bangham CR
J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
[TBL] [Abstract][Full Text] [Related]
5. Immunity to Respiratory Infection Is Reinforced Through Early Proliferation of Lymphoid T
Suarez-Ramirez JE; Chandiran K; Brocke S; Cauley LS
Front Immunol; 2019; 10():1370. PubMed ID: 31258537
[TBL] [Abstract][Full Text] [Related]
6. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
[TBL] [Abstract][Full Text] [Related]
7. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.
Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523
[TBL] [Abstract][Full Text] [Related]
8. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.
Hemann EA; Kang SM; Legge KL
J Immunol; 2013 Sep; 191(5):2486-94. PubMed ID: 23885108
[TBL] [Abstract][Full Text] [Related]
9. Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.
Zacharias ZR; Ross KA; Hornick EE; Goodman JT; Narasimhan B; Waldschmidt TJ; Legge KL
Front Immunol; 2018; 9():1953. PubMed ID: 30233573
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.
Hemann EA; Sjaastad LE; Langlois RA; Legge KL
J Virol; 2015 Dec; 90(6):2830-7. PubMed ID: 26719269
[TBL] [Abstract][Full Text] [Related]
11. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.
Dhakal S; Loube J; Misplon JA; Lo CY; Creisher PS; Mulka KR; Deshpande S; Mitzner W; Klein SL; Epstein SL
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627390
[TBL] [Abstract][Full Text] [Related]
12. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
Baaten BJ; Clarke B; Strong P; Hou S
Vaccine; 2010 Jun; 28(25):4130-7. PubMed ID: 20433805
[TBL] [Abstract][Full Text] [Related]
13. Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions.
Coleclough C; Sealy R; Surman S; Marshall DR; Hurwitz JL
Scand J Immunol; 2005 Jul; 62 Suppl 1():73-83. PubMed ID: 15953188
[TBL] [Abstract][Full Text] [Related]
14. Memory regulatory T cells home to the lung and control influenza A virus infection.
Lu C; Zanker D; Lock P; Jiang X; Deng J; Duan M; Liu C; Faou P; Hickey MJ; Chen W
Immunol Cell Biol; 2019 Oct; 97(9):774-786. PubMed ID: 31116465
[TBL] [Abstract][Full Text] [Related]
15. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
16. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
17. FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
Ochsner SP; Li W; Rajendrakumar AM; Palaniyandi S; Acharya G; Liu X; Wang G; Krammer F; Shi M; Tuo W; Pauza CD; Zhu X
J Immunol; 2021 Sep; 207(5):1310-1321. PubMed ID: 34380652
[TBL] [Abstract][Full Text] [Related]
18. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
[TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung.
Zhou AC; Wagar LE; Wortzman ME; Watts TH
Mucosal Immunol; 2017 Sep; 10(5):1294-1309. PubMed ID: 28051085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
